Beijing Second Pharmaceutical Co., Ltd. (BSPC) has received FDA approval of its ANDA 090752 for Amlodipine Besylate, a generic form of Pfizer’s Norvasc. BSPC is a China-based generic pharmaceutical company focused on manufacturing ophthalmic dosage forms and oral solid dosages targeted for cardiovascular therapies at its EU and U.S. cGMP-compliant finished product and API facilities. With this approval, BSPC will become the first Chinese-owned pharma firm to be able to launch an FDA-approved ...